TRANSCHEM LTD. SHARE PRICE [LIVE]
BSE: INE019B01010 NSE: TRANSCHEM SECTOR: Pharma
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Mar 21 | Dec 20 |
|---|
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in TRANSCHEM LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
TRANSCHEM News
- AMARA RAJA BATTERIES LTD
- BFL ASSET FINVEST LIMITED
- ZODIAC CLOTHING CO.LTD.
- SCAN STEELS LIMITED
- CLASSIC LEASING & FINANCE LTD
- ZF COMMERCIAL VEHICLE CONTROL SYSTEMS INDIA LIMITED
- HP ADHESIVES LIMITED
- UNIINFO TELECOM SERVICES LIMITED
- SHARP INDIA LIMITED
- BALAJI TELEFILMS LTD.
- NARAYANI STEELS LIMITED
- BRAHMAPUTRA INFRASTRUCTURE LTD.
- BLOOM DEKOR LTD.
- BOMBAY DYEING & MFG CO LTD
- UPSURGE INVESTMENT & FINANCE LTD.
- TRITON VALVES LTD.
- ANNA INFRASTRUCTURES LTD.
- KARAN WOO-SIN LTD.
- POLY MEDICURE LTD.
- WEALTH FIRST PORTFOLIO MANAGERS LIMITED
Frequently Asked Questions
What is the Share price of TRANSCHEM LTD. (TRANSCHEM)?
Can I buy TRANSCHEM LTD. (TRANSCHEM) shares?
How do I buy TRANSCHEM LTD. (TRANSCHEM) from Angel One?
- Direct investment: You can buy TRANSCHEM LTD. (TRANSCHEM) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to TRANSCHEM LTD. (TRANSCHEM) shares.
In which sector do TRANSCHEM LTD. (TRANSCHEM) belong?
About TRANSCHEM
Today's live share price for TRANSCHEM LTD. is NSE: N/A, BSE: ₹ 20.95 with a current market capitalization of .
Transchem (TL) was incorporated as a private limited company on 18 Nov.'76 and converted into a public limited company on 13 Apr.'92. The company is promoted by Chemitex Corporation in association with Rajen Desai,who is the chairman of the company. TL came out with a public issue of 14.22 lac zero-interest FCDs of Rs.120.00 at par aggregating Rs.17.07 crores in Oct.'93, to meet part of the capital cost, and to finance the margin money for working capital, etc, at a project cost of Rs.27.00 crores. The company manufactures bulk drugs in Maharashtra. The company's main products are frusemide, fenbendazole and albendazoie. TL has signed an MoU with Dalsem Reciap Agro Industries, Holland, for their mushroom project -- a 100% EOU -- with buy-back arrangement for a period of 5 years, extendable for another 5 years. The company exports to the US, Canada, Mexico, etc. The company is diversifying into mushroom cultivation. TL is also in the process of finalising collaboration with FTC, Holland, for technological transfer in growing asparagus, strawberries and raspberries. During the year 1999-2000, the mushroom division did well and the sale of Diminazine Aceturate indicate that the company is emerging as a front runner in the product. The company has finalised and commercialised process for Cloursulon and Toldium Phos Sodium. The company has got a contract during the year 2000-01,from an international firm to supply Triclabendazole.
Read more
